Market revenue in 2023 | USD 22.9 million |
Market revenue in 2030 | USD 31.2 million |
Growth rate | 4.5% (CAGR from 2023 to 2030) |
Largest segment | Carbohydrates |
Fastest growing segment | Carbohydrates |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Other Chemical Natures |
Key market players worldwide | Basf SE, Lonza Group Ltd, Evonik Industries AG, Roquette America, JRS Pharma, Micro Powders, Fumeipharm, Cristalco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plant-based excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 21.4% in 2023. Horizon Databook has segmented the Sweden plant-based excipients market based on carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, ethers & carboxylic acids, other chemical natures covering the revenue growth of each sub-segment from 2018 to 2030.
Cancer is one of the leading causes of mortality in Sweden. According to GLOBOCAN 2020, 24,464 cancer deaths occurred in the country. In 2020, approximately 62,494 new cancer cases were diagnosed. To reduce the burden of cancer, the new EU Cancer Plan was introduced by the Swedish government.
This plan emphasized improving the treatment of cancer. This is expected to improve the demand for plant-based excipients for use in cancer over the forecast period. There has been significant growth in pharmaceutical exports from Sweden.
For instance, Swedish pharmaceutical exports totaled over USD 6.6 billion (SEK 70 billion) in the first half of 2022 alone, accounting for a rise of nearly 40% from the first half of 2021. Similar growth in the future is expected to improve the demand for plant-based excipients due to the low toxicity and high affordability of these excipients.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden plant-based excipients market , including forecasts for subscribers. This country databook contains high-level insights into Sweden plant-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account